Evidence map›Paper›PMID 41663813›Full record

ArticleNature immunology2026

Distinct spatial organization governs oral mucosal immunity.

Vasileios I Theofilou, David Fraser, Eleni Kanasi, Laurie Brenchley, Teresa Greenwell-Wild, Emmanuel E Adade, Alex M Valm, Iyadh Douagi, Yasmine Belkaid, Duy T Tran and 2 more

Abstract read
In one paragraph

Article in Nature immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Vasileios I TheofilouHuman Barrier Immunity Section, Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
David FraserNational Institute of Dental and Craniofacial Research, NIH, Bethesda, MD, USA.ORCID http://orcid.org/0000-0003-3995-2503
Eleni KanasiHuman Barrier Immunity Section, Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Laurie BrenchleyHuman Barrier Immunity Section, Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Teresa Greenwell-WildHuman Barrier Immunity Section, Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Emmanuel E AdadeDepartment of Biological Sciences, University at Albany State University of New York, Albany, NY, USA.
Alex M ValmDepartment of Biological Sciences, University at Albany State University of New York, Albany, NY, USA.
Iyadh DouagiNIH Center for Human Immunology, Autoimmunity, and Inflammation (CHI), NIAID, NIH, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-3221-8667
Yasmine BelkaidMetaorganism Unit, Department of Immunology, Institut Pasteur, Paris, France.
Duy T TranNational Eye Institute, NIH, Bethesda, MD, USA.
Drake W WilliamsDepartment of Diagnostic and Biological Sciences, University of Minnesota, Minneapolis, MN, USA. drakew@umn.edu.ORCID http://orcid.org/0000-0002-7718-2098
Niki M MoutsopoulosHuman Barrier Immunity Section, Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA. nmoutsop@mail.nih.gov.ORCID http://orcid.org/0000-0002-7365-6735

Funding

Oral microbial community structure and assembly: from molecule to microbiomeR01DE030927 · NIDCR · STATE UNIVERSITY OF NEW YORK AT ALBANY · PI VALM, ALEX M · 2021 to 2025
$1.8M
T cell response in Aggregatibacter actinomycetemcomitans-associated periodontal diseaseR00DE032747 · NIDCR · UNIVERSITY OF MINNESOTA · PI Drake Winslow Williams · 2025 to 2026
$494k
NIDCR NIH HHS R00 DE032747U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (NIDCR) R00DE032747U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (NIDCR) R01DE030927
6 · The paper itself

Abstract

Immune responsiveness at barrier surfaces is tailored to the exposures of each tissue. In the oral mucosa, mechanisms by which a permeable epithelium coexists with diverse microbiota and maintains integrity during inflammatory pathology remain poorly understood. We compile a multiomics spatial map of this exposed mucosal microenvironment and uncover remarkable immune zonation with organization that is preserved even during inflammatory disease. At the tooth interface, we identify a dynamic epithelium underlined by a layer of neutrophils and a zone of antigen-presenting cell-lymphocyte aggregates. During disease, inflammatory zones expand and organize into immature tertiary lymphoid structures, suggesting local antibody production. Location-specific transcriptomes support a role for the stromal compartment in the spatial organization of immunity. This preserved immune zonation meets the demands for continuous protection of this vulnerable interface and suggests unique tissue-specific wiring of immunity at the human oral mucosal barrier.

Indexed as

Immunity, MucosalMouth MucosaAnimalsAntigen-Presenting CellsCellular MicroenvironmentHumansMultiomicsNeutrophilsTranscriptome

Identifiers

PMID41663813
PMCPMC12956602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.